Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EmeisWBO:ORP2 -3.28%53 EV-to-OCF is 17.40 as of Aug. 11, 2026, which is 29% below its 10-year median of 24.58. GuruFocus rates WBO:ORP2 with a GF Score™ of 53/100 and a GF Value™ of €11.28 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Emeis ranks worse than 73.13% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Emeis's Enterprise Value is €10,453 Mil.
Emeis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €601 Mil. Therefore, Emeis's EV-to-OCF for today is 17.40.
The historical rank and industry rank for Emeis's EV-to-OCF or its related term are showing as below:
WBO:ORP2'
s EV-to-OCF Range Over the Past 10 Years
Min: 15.12 Med: 24.58 Max: 31.84
Current: 17.51
During the past 13 years, the highest EV-to-OCF of Emeis was 31.84. The lowest was 15.12. And the median was 24.58.
WBO:ORP2's EV-to-OCF is ranked worse than 73.13% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 8.95
vs WBO:ORP2: 17.51
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-11), Emeis's stock price is €14.16.
Emeis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.250. Therefore, Emeis's PE Ratio (TTM) for today is At Loss.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Emeis's share price for today is €14.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Emeis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €-1.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Emeis EV-to-OCF Related Terms
Emeis EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Emeis's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Emeis's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emeis EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Emeis's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Emeis's EV-to-OCF falls into.
Emeis's current Enterprise Value is €10,453 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Emeis's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €601 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emeis (WBO:ORP2) has a EV-to-OCF of 17.40 as of Aug. 11, 2026. This is 29% below median its historical median of 24.58. Over the past decade, Emeis' EV-to-OCF has ranged from 15.12 to 31.84. According to the industry distribution chart, Emeis ranks #498 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 73.1%.
Is Emeis' EV-to-OCF too high?
Emeis' current EV-to-OCF of 17.40 is 29% below median its 10-year median of 24.58. Over the past 10 years, this metric has ranged from a low of 15.12 to a high of 31.84. The Healthcare Providers & Services industry median EV-to-OCF is 8.95. Emeis' value of 17.40 is 94.4% above this industry median. Based on the distribution chart, Emeis ranks #498 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Emeis has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emeis' EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Emeis ranks #498 out of 681 companies for EV-to-OCF. This places Emeis in the lower half of its industry. The industry median EV-to-OCF is 8.95. Emeis' value of 17.40 is 94.4% above this benchmark. Historically, Emeis' own EV-to-OCF has ranged from 15.12 to 31.84 over the past decade. While the company's 10-year median is 24.58 vs. the industry median of 8.95, Emeis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emeis's current EV-to-OCF of 17.40 is 94.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emeis's current EV-to-OCF is 17.40, which is 29% below median its own 10-year median of 24.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emeis stock overvalued right now?
Based on GuruFocus' analysis, Emeis (WBO:ORP2) is currently considered Modestly Overvalued. The stock's GF Value™ is €11.28, compared to a current price of €14.16 — trading 25.5% above its estimated fair value. The current EV-to-OCF is 17.40, which is 29% below median its 10-year median of 24.58 and 94.4% above the Healthcare Providers & Services industry median of 8.95. Emeis' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Emeis (WBO:ORP2), the current EV-to-OCF is 17.40 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Emeis (WBO:ORP2) Overvalued in 2026?
Based on GuruFocus' analysis, Emeis stock appears to be overvalued.
The current stock price of €14.16 is trading 25.5% above its estimated GF Value™ of €11.28.
GuruFocus considers Emeis to be Modestly Overvalued.
Key valuation signals for WBO:ORP2:
EV-to-OCF: 17.40 (29% below median its 10-year median of 24.58)
GF Value™: €11.28 vs. price of €14.16 (25.5% above fair value)
Industry Position: 94.4% above the Healthcare Providers & Services median (#498 of 681)
No single metric tells the full story. See the WBO:ORP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Emeis operates a comprehensive care offering of mental health clinics and medical and rehabilitation care, retirement homes, assisted living and home care.
53GF Score
Get the complete analysis for WBO:ORP2
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ORP2 has been successfully added to your 
